Conversation with The Cancer LetterReal-world Evidence RWD company documents baseline trends in women’s cancers before Trump’s policy changes January 24, 2025Vol.51 No.03By Claire Marie Porter
Real-world Evidence Flatiron, Caris combine EHR, multi-omics data to support precision oncology January 26, 2024Vol.50 No.04By Matthew Bin Han Ong
Real-world Evidence Real-world tumor response rate can serve as a clinical endpoint, Friends pilot study showsFDA says raw images enrich the data when used with clinician assessments October 06, 2023Vol.49 No.37By Matthew Bin Han Ong
Real-world Evidence Robert Winn, Rebecca Miksad, Dana Rollison: We must use real-world data and lessons from COVID to improve care, equity in communities we serve May 13, 2022Vol.48 No.19By Matthew Bin Han Ong
Real-world Evidence Epic EHR data: Cancer screenings nosedive in 2021 despite easing of COVID restrictions September 17, 2021Vol.47 No.34By Matthew Bin Han Ong
Conversation with The Cancer LetterReal-world Evidence Here’s something for the Bidens and ARPA-H to do: Build a national, federated ecosystem for digital health, MITRE proposes May 21, 2021Vol.47 No.20By Matthew Bin Han Ong
Real-world Evidence Cancer trials are getting harder to complete, suggesting a role for more powerful RWE, AI solutions May 14, 2021Vol.47 No.19By Matthew Bin Han Ong
Real-world Evidence Study of NSCLC, melanoma outcomes points to surrogacy between real-world endpoints and clinical trial endpoints September 25, 2020Vol.46 No.36By Matthew Bin Han Ong
Conversation with The Cancer LetterFreeReal-world Evidence Learning to harmonize: Ten health care research organizations tell us how they formulated common definitions for real-world endpoints November 22, 2019Vol.45 No.44By Matthew Bin Han Ong
Conversation with The Cancer LetterFreeReal-world Evidence Friends’ Allen: Real-world endpoints can be used to fill evidence gaps about performance of medical products November 22, 2019Vol.45 No.44By Matthew Bin Han Ong
